Logo image of CREX

CREATIVE REALITIES INC (CREX) Stock Fundamental Analysis

USA - NASDAQ:CREX - US22530J3095 - Common Stock

2.93 USD
0 (0%)
Last: 10/31/2025, 8:00:01 PM
2.79 USD
-0.14 (-4.78%)
After Hours: 10/31/2025, 8:00:01 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CREX. CREX was compared to 94 industry peers in the Media industry. CREX may be in some trouble as it scores bad on both profitability and health. CREX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CREX had positive earnings in the past year.
CREX had a negative operating cash flow in the past year.
In multiple years CREX reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: CREX reported negative operating cash flow in multiple years.
CREX Yearly Net Income VS EBIT VS OCF VS FCFCREX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M

1.2 Ratios

CREX's Return On Assets of -1.94% is in line compared to the rest of the industry. CREX outperforms 46.81% of its industry peers.
CREX has a Return On Equity (-4.19%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -1.94%
ROE -4.19%
ROIC N/A
ROA(3y)-2.23%
ROA(5y)-17.47%
ROE(3y)-5.54%
ROE(5y)-80.4%
ROIC(3y)N/A
ROIC(5y)N/A
CREX Yearly ROA, ROE, ROICCREX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

The Gross Margin of CREX (43.41%) is comparable to the rest of the industry.
CREX's Gross Margin has improved in the last couple of years.
CREX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.36%
GM growth 5Y1.66%
CREX Yearly Profit, Operating, Gross MarginsCREX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

CREX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CREX has been increased compared to 1 year ago.
The number of shares outstanding for CREX has been increased compared to 5 years ago.
The debt/assets ratio for CREX is higher compared to a year ago.
CREX Yearly Shares OutstandingCREX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
CREX Yearly Total Debt VS Total AssetsCREX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

CREX has an Altman-Z score of 0.00. This is a bad value and indicates that CREX is not financially healthy and even has some risk of bankruptcy.
CREX has a Altman-Z score of 0.00. This is in the lower half of the industry: CREX underperforms 71.28% of its industry peers.
A Debt/Equity ratio of 0.68 indicates that CREX is somewhat dependend on debt financing.
CREX has a Debt to Equity ratio (0.68) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Altman-Z 0
ROIC/WACCN/A
WACC7.19%
CREX Yearly LT Debt VS Equity VS FCFCREX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

A Current Ratio of 1.01 indicates that CREX should not have too much problems paying its short term obligations.
The Current ratio of CREX (1.01) is comparable to the rest of the industry.
CREX has a Quick Ratio of 1.01. This is a bad value and indicates that CREX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.93, CREX is not doing good in the industry: 62.77% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.01
Quick Ratio 0.93
CREX Yearly Current Assets VS Current LiabilitesCREX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 488.89% over the past year.
The Revenue has decreased by -6.24% in the past year.
Measured over the past years, CREX shows a quite strong growth in Revenue. The Revenue has been growing by 9.98% on average per year.
EPS 1Y (TTM)488.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-183.33%
Revenue 1Y (TTM)-6.24%
Revenue growth 3Y40.23%
Revenue growth 5Y9.98%
Sales Q2Q%-0.65%

3.2 Future

Based on estimates for the next years, CREX will show a very strong growth in Earnings Per Share. The EPS will grow by 50.60% on average per year.
CREX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.12% yearly.
EPS Next Y137.09%
EPS Next 2Y50.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.81%
Revenue Next 2Y11.12%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CREX Yearly Revenue VS EstimatesCREX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
CREX Yearly EPS VS EstimatesCREX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -1 -2 -3

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 8.37, which indicates a very decent valuation of CREX.
Based on the Price/Earnings ratio, CREX is valued cheaper than 80.85% of the companies in the same industry.
CREX is valuated cheaply when we compare the Price/Earnings ratio to 26.10, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 33.14 indicates a quite expensive valuation of CREX.
CREX's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of CREX to the average of the S&P500 Index (22.52), we can say CREX is valued slightly more expensively.
Industry RankSector Rank
PE 8.37
Fwd PE 33.14
CREX Price Earnings VS Forward Price EarningsCREX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

CREX's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.14
CREX Per share dataCREX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

CREX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CREX's earnings are expected to grow with 50.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.06
PEG (5Y)N/A
EPS Next 2Y50.6%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CREX!.
Industry RankSector Rank
Dividend Yield N/A

CREATIVE REALITIES INC

NASDAQ:CREX (10/31/2025, 8:00:01 PM)

After market: 2.79 -0.14 (-4.78%)

2.93

0 (0%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)08-13 2025-08-13/bmo
Earnings (Next)11-11 2025-11-11/bmo
Inst Owners14.87%
Inst Owner Change-0.05%
Ins Owners16.83%
Ins Owner Change22.55%
Market Cap30.82M
Revenue(TTM)48.22M
Net Income(TTM)-1233000
Analysts84
Price Target6.76 (130.72%)
Short Float %1.26%
Short Ratio1.31
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)225.73%
Min EPS beat(2)-149.99%
Max EPS beat(2)601.45%
EPS beat(4)2
Avg EPS beat(4)117.54%
Min EPS beat(4)-149.99%
Max EPS beat(4)601.45%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.64%
Min Revenue beat(2)-11.52%
Max Revenue beat(2)6.23%
Revenue beat(4)3
Avg Revenue beat(4)0.2%
Min Revenue beat(4)-11.52%
Max Revenue beat(4)6.23%
Revenue beat(8)4
Avg Revenue beat(8)-1.96%
Revenue beat(12)4
Avg Revenue beat(12)-3.57%
Revenue beat(16)4
Avg Revenue beat(16)-3.18%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-189.48%
EPS NY rev (1m)0%
EPS NY rev (3m)-71.08%
Revenue NQ rev (1m)-4.73%
Revenue NQ rev (3m)-18.46%
Revenue NY rev (1m)-1.24%
Revenue NY rev (3m)-5.92%
Valuation
Industry RankSector Rank
PE 8.37
Fwd PE 33.14
P/S 0.64
P/FCF N/A
P/OCF N/A
P/B 1.05
P/tB N/A
EV/EBITDA 16.14
EPS(TTM)0.35
EY11.95%
EPS(NY)0.09
Fwd EY3.02%
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS4.58
BVpS2.8
TBVpS-1.78
PEG (NY)0.06
PEG (5Y)N/A
Graham Number4.69
Profitability
Industry RankSector Rank
ROA -1.94%
ROE -4.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.41%
FCFM N/A
ROA(3y)-2.23%
ROA(5y)-17.47%
ROE(3y)-5.54%
ROE(5y)-80.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.36%
GM growth 5Y1.66%
F-Score3
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Debt/EBITDA 6.52
Cap/Depr 54.53%
Cap/Sales 5.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.01
Quick Ratio 0.93
Altman-Z 0
F-Score3
WACC7.19%
ROIC/WACCN/A
Cap/Depr(3y)115.1%
Cap/Depr(5y)95.1%
Cap/Sales(3y)8.11%
Cap/Sales(5y)6.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)488.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-183.33%
EPS Next Y137.09%
EPS Next 2Y50.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.24%
Revenue growth 3Y40.23%
Revenue growth 5Y9.98%
Sales Q2Q%-0.65%
Revenue Next Year2.81%
Revenue Next 2Y11.12%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-161.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year580.51%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-268.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-100.91%
OCF growth 3Y93.04%
OCF growth 5YN/A

CREATIVE REALITIES INC / CREX FAQ

Can you provide the ChartMill fundamental rating for CREATIVE REALITIES INC?

ChartMill assigns a fundamental rating of 3 / 10 to CREX.


What is the valuation status for CREX stock?

ChartMill assigns a valuation rating of 5 / 10 to CREATIVE REALITIES INC (CREX). This can be considered as Fairly Valued.


What is the profitability of CREX stock?

CREATIVE REALITIES INC (CREX) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for CREX stock?

The Earnings per Share (EPS) of CREATIVE REALITIES INC (CREX) is expected to grow by 137.09% in the next year.